TABLE I.
Percent differences between measured and calculated doses | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Plan | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Acceptable (Y/N) |
GI 1 | 4.2% | 6.0% | 5.9% | 5.7% | 6.1% | 3.5% | 3.1% | 5.4% | 0.7% | N | |
GI 2 | 5.1% | 6.6% | 4.8% | 1.2% | 2.0% | 6.2% | 5.4% | 5.2% | 1.4% | 2.3% | N |
GI 3 | −0.7% | 2.0% | 1.2% | 5.5% | 5.1% | −1.2% | N | ||||
GI 4 | −0.4% | −0.1% | 0.8% | 0.9% | 0.7% | 1.0% | 1.3% | 0.8% | 1.0% | Y | |
GI 5 | −2.7% | −1.2% | −0.4% | −3.2% | −1.0% | −2.1% | −1.8% | −0.7% | Y | ||
GU | −2.8% | −2.1% | −1.6% | −2.8% | −2.8% | −0.8% | −3.3% | Y | |||
Gyn 1 | −2.1% | −1.8% | −2.7% | −0.8% | −1.2% | −1.9% | 0.5% | −0.8% | −1.3% | Y | |
Gyn 2 | 2.9% | 1.6% | 3.1% | 1.7% | 2.7% | 2.7% | 1.5% | 7.4% | N | ||
HN 1 | −3.3% | −1.7% | −2.0% | −3.4% | −2.5% | −1.4% | −1.5% | Y | |||
HN 2 | 0.4% | −1.1% | −2.0% | −0.2% | 0.7% | 1.3% | −0.2% | −1.2% | Y | ||
HN 3 | −0.7% | −0.8% | −0.9% | −0.9% | 0.3% | −2.4% | Y | ||||
HN 4 | −1.7% | −2.7% | −5.1% | −1.0% | −2.9% | 0.0% | −5.5% | N | |||
HN 5 | −2.6% | −0.6% | −2.1% | −2.1% | −1.4% | 3.6% | −0.1% | Y | |||
Lung stereo | −1.7% | −4.7% | −1.7% | −4.9% | N | ||||||
Mantle | −2.7% | −0.9% | −7.3% | −5.5% | −6.2% | N | |||||
Meso 1 | 4.3% | 5.3% | 6.3% | 4.0% | 1.6% | 5.3% | 2.4% | 5.3% | 4.8% | 4.7% | N |
Meso 2 | 7.4% | 4.8% | 5.2% | 1.6% | 5.4% | 4.5% | 3.2% | 2.3% | N | ||
Meso 3 | 3.8% | 3.6% | 1.7% | 3.1% | 4.1% | 2.0% | 4.3% | 2.2% | N | ||
Meso 4 | 6.8% | 4.6% | 3.4% | 2.8% | 1.3% | 7.5% | 4.0% | 5.7% | N | ||
Rib stereo | −2.1% | −4.4% | −4.9% | −3.4% | N | ||||||
Spine stereo | −6.8% | −2.3% | −4.8% | −5.0% | N | ||||||
Thoracic 1 | −5.2% | −5.2% | −0.2% | −6.3% | −5.4% | −8.0% | −4.4% | N | |||
Thoracic 2 | −3.5% | −2.9% | −2.6% | −3.5% | −4.9% | −1.6% | −1.3% | −3.4% | 0.1% | N | |
Thoracic 3 | −2.1% | −1.4% | −1.2% | −2.5% | −3.1% | −1.2% | −1.8% | −0.3% | −3.3% | −0.4% | Y |